Biofrontera Statistics Share Statistics Biofrontera has 10.67M
shares outstanding. The number of shares has increased by 70.4%
in one year.
Shares Outstanding 10.67M Shares Change (YoY) 70.4% Shares Change (QoQ) 6.45% Owned by Institutions (%) 0.02% Shares Floating 8.26M Failed to Deliver (FTD) Shares 11 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 136.54K, so 1.28% of the outstanding
shares have been sold short.
Short Interest 136.54K Short % of Shares Out 1.28% Short % of Float 1.31% Short Ratio (days to cover) 1.64
Valuation Ratios The PE ratio is -0.34 and the forward
PE ratio is 16.
Biofrontera's PEG ratio is
0.
PE Ratio -0.34 Forward PE 16 PS Ratio 0.16 Forward PS 0.2 PB Ratio 1.36 P/FCF Ratio -0.58 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Biofrontera.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.72,
with a Debt / Equity ratio of 1.11.
Current Ratio 1.72 Quick Ratio 1.17 Debt / Equity 1.11 Debt / EBITDA -0.34 Debt / FCF -0.48 Interest Coverage -8.17
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $405.47K Profits Per Employee $-193.03K Employee Count 92 Asset Turnover 1.69 Inventory Turnover 2.8
Taxes Income Tax 22K Effective Tax Rate -0.12%
Stock Price Statistics The stock price has increased by -25% in the
last 52 weeks. The beta is 0.5, so Biofrontera's
price volatility has been higher than the market average.
Beta 0.5 52-Week Price Change -25% 50-Day Moving Average 0.93 200-Day Moving Average 0.89 Relative Strength Index (RSI) 58.14 Average Volume (20 Days) 228,193
Income Statement In the last 12 months, Biofrontera had revenue of 37.3M
and earned -17.76M
in profits. Earnings per share was -3.22.
Revenue 37.3M Gross Profit 18.7M Operating Income -17.21M Net Income -17.76M EBITDA -14.44M EBIT -15.63M Earnings Per Share (EPS) -3.22
Full Income Statement Balance Sheet The company has 5.91M in cash and 4.92M in
debt, giving a net cash position of 983K.
Cash & Cash Equivalents 5.91M Total Debt 4.92M Net Cash 983K Retained Earnings -117.41M Total Assets 20.14M Working Capital -872K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.27M
and capital expenditures -10K, giving a free cash flow of -10.28M.
Operating Cash Flow -10.27M Capital Expenditures -10K Free Cash Flow -10.28M FCF Per Share -1.86
Full Cash Flow Statement Margins Gross margin is 50.12%, with operating and profit margins of -46.14% and -47.61%.
Gross Margin 50.12% Operating Margin -46.14% Pretax Margin -47.55% Profit Margin -47.61% EBITDA Margin -38.71% EBIT Margin -46.14% FCF Margin -27.56%
Dividends & Yields BFRI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for BFRI is $2.75,
which is 186.5% higher than the current price. The consensus rating is "Buy".
Price Target $2.75 Price Target Difference 186.5% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 5, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Jul 5, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -9.4 Piotroski F-Score 3
